Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors Journal:Journal for ImmunoTherapy of Cancer | 2021 | ||
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib Journal:Expert Review of Gastroenterology and Hepatology | 2021 | ||
2021 | |||
2021 |